Renlin Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renlin Yu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ju Cao
Department of Laboratory Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
3 shared publications Jiayu Liu
2 shared publications- Mengxue Liu
Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
2 shared publications Yue Li
Department of Laboratory Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
2 shared publications- Banglao Xu
Department of Laboratory Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China
1 shared publication - Fang Xu
Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (8) , 5086-5107
Progranulin drives acetaminophen-induced acute liver injury by limiting hepatic recruitment of eosinophils via suppressing interleukin-33 expression
- 13 February 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (8) , 5086-5107
Open AccessProgranulin drives acetaminophen-induced acute liver injury by limiting hepatic recruitment of eosinophils via suppressing interleukin-33 expression
- 28 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (834) , eadw8481
Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans
Invasive candidiasis is a leading cause of nosocomial bloodstream infection associated with high mortality, and there is a pressing need to develop biomarker-guided antifungal therapy to improve clinical outcomes. Meteorin-like (METRNL) is a cytokine that can act as a high-affinity ligand for the stem cell factor receptor KIT; however, the functional role of METRNL in fungal infection remains unclear. Here, we found that METRNL acts as a disease-promoting immune checkpoint to facilitate invasive Candida albicans ( C. albicans ) infection. Mice deficient in METRNL were refractory to a lethal systemic infection with C. albicans. Treatment with a METRNL blocking antibody protected mice from invasive C. albicans infection, whereas treatment with recombinant METRNL or overexpression of endogenous METRNL dampened fungal clearance and aggravated disease mortality but not in mice with macrophage-specific deletion of KIT. The METRNL-KIT axis decreased dectin-1 expression and impaired fungal phagocytosis and killing capacity in macrophages, which was dependent on signal transducer and activator of transcription 3 signaling, thereby negatively regulating host antifungal immunity. In two independent cohorts, patients with candidemia had elevated circulating METRNL concentrations compared with patients with bacteremia or healthy volunteers. In both cohorts, a higher circulating METRNL concentration was associated with poor survival. Therefore, our study provides mechanistic and translational insights into how METRNL orchestrates macrophage-dependent antifungal immunity, implying that a potential theranostic approach involving blood-circulating METRNL-guided patient stratification and targeted therapy of blocking METRNL may help improve the management of human fungal disease through a precision medicine strategy.
- 28 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (834) , eadw8481
Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans
Invasive candidiasis is a leading cause of nosocomial bloodstream infection associated with high mortality, and there is a pressing need to develop biomarker-guided antifungal therapy to improve clinical outcomes. Meteorin-like (METRNL) is a cytokine that can act as a high-affinity ligand for the stem cell factor receptor KIT; however, the functional role of METRNL in fungal infection remains unclear. Here, we found that METRNL acts as a disease-promoting immune checkpoint to facilitate invasive Candida albicans ( C. albicans ) infection. Mice deficient in METRNL were refractory to a lethal systemic infection with C. albicans. Treatment with a METRNL blocking antibody protected mice from invasive C. albicans infection, whereas treatment with recombinant METRNL or overexpression of endogenous METRNL dampened fungal clearance and aggravated disease mortality but not in mice with macrophage-specific deletion of KIT. The METRNL-KIT axis decreased dectin-1 expression and impaired fungal phagocytosis and killing capacity in macrophages, which was dependent on signal transducer and activator of transcription 3 signaling, thereby negatively regulating host antifungal immunity. In two independent cohorts, patients with candidemia had elevated circulating METRNL concentrations compared with patients with bacteremia or healthy volunteers. In both cohorts, a higher circulating METRNL concentration was associated with poor survival. Therefore, our study provides mechanistic and translational insights into how METRNL orchestrates macrophage-dependent antifungal immunity, implying that a potential theranostic approach involving blood-circulating METRNL-guided patient stratification and targeted therapy of blocking METRNL may help improve the management of human fungal disease through a precision medicine strategy.
- 20 January 2024
- Published by Elsevier in Microbes and Infection
- Vol. 26 (4) , 105302
Elevated serum level of progranulin is associated with increased mortality in critically ill patients with candidemia
- 20 January 2024
- Published by Elsevier in Microbes and Infection
- Vol. 26 (4) , 105302
Elevated serum level of progranulin is associated with increased mortality in critically ill patients with candidemia